Axim Biotechnologies has also strengthened its patent portfolio having secured a patent allowance for its suppository formulations for cannabinoids . Read More
The post Axim Biotechnologies Inc (OTCMKTS:AXIM) Due For A Bounce appeared first on Dagga Magazine.